M. E. MAVİ Et Al. , "Role of FDG PET/CT in the Evaluation of Therapy Response in Systemic Juvenile Xanthogranuloma," CLINICAL NUCLEAR MEDICINE , vol.47, no.5, 2022
MAVİ, M. E. Et Al. 2022. Role of FDG PET/CT in the Evaluation of Therapy Response in Systemic Juvenile Xanthogranuloma. CLINICAL NUCLEAR MEDICINE , vol.47, no.5 .
MAVİ, M. E., Turan, B. S., VOLKAN SALANCI, B., & BOZKURT, M. F., (2022). Role of FDG PET/CT in the Evaluation of Therapy Response in Systemic Juvenile Xanthogranuloma. CLINICAL NUCLEAR MEDICINE , vol.47, no.5.
MAVİ, MEHMET Et Al. "Role of FDG PET/CT in the Evaluation of Therapy Response in Systemic Juvenile Xanthogranuloma," CLINICAL NUCLEAR MEDICINE , vol.47, no.5, 2022
MAVİ, MEHMET E. Et Al. "Role of FDG PET/CT in the Evaluation of Therapy Response in Systemic Juvenile Xanthogranuloma." CLINICAL NUCLEAR MEDICINE , vol.47, no.5, 2022
MAVİ, M. E. Et Al. (2022) . "Role of FDG PET/CT in the Evaluation of Therapy Response in Systemic Juvenile Xanthogranuloma." CLINICAL NUCLEAR MEDICINE , vol.47, no.5.
@article{article, author={MEHMET EMİN MAVİ Et Al. }, title={Role of FDG PET/CT in the Evaluation of Therapy Response in Systemic Juvenile Xanthogranuloma}, journal={CLINICAL NUCLEAR MEDICINE}, year=2022}